Qiagen N.V.
QGEN- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001015820
No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.
Superinvestors holding QGEN, Q2 2026
No superinvestor reported holding QGEN in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of QGEN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+53.0%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+27.9%)
Q4 2022
1 superinvestor holding at quarter end